In men , the Havrix group showed a significantly higher seroconversion rate ( @ % ) than the Epaxal group ( @ % ) , whereas both vaccine groups showed similarly high immunogenicity in women ( Havrix : @ % , Epaxal : @ % ; P for interaction = @ ) .